{
  "meta": {
    "data_length": 1,
    "message": "Therapy name Durvalumab retrieved successfully",
    "request_url": "http://api.moalmanac.org/therapies?therapy_name=Durvalumab",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.004692,
    "timestamp_received": "2026-04-23T19:02:33.669427+00:00Z",
    "timestamp_returned": "2026-04-23T19:02:33.674119+00:00Z",
    "trace_id": "e6b0d8a4-6b1e-4475-8cc5-b142b470636f"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-04-09"
  },
  "data": [
    {
      "id": 44,
      "conceptType": "Drug",
      "name": "Durvalumab",
      "primaryCoding": {
        "id": "ncit:C103194",
        "code": "C103194",
        "name": "Durvalumab",
        "system": "https://evsexplore.semantics.cancer.gov",
        "systemVersion": "25.01d",
        "iris": [
          "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C103194"
        ]
      },
      "mappings": [],
      "extensions": [
        {
          "name": "therapy_strategy",
          "value": [
            "PD-1/PD-L1 inhibition"
          ],
          "description": "Associated therapeutic strategy or mechanism of action of the therapy."
        },
        {
          "name": "therapy_type",
          "value": "Immunotherapy",
          "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
        }
      ]
    }
  ]
}